Nobuyuki Imai

Designed catalyst for enantioselective Diels-Alder addition from a C2-symmetric chiral bis(oxazoline)-iron(III) complex

E. J. Corey, Nobuyuki Imai, Hong Yue Zhang · Journal of the American Chemical Society · 1991 · 442 citations

Natural Sciences, Chemistry, Catalysis +15

Toxicity, pharmacokinetics, and dose-finding study of repetitive treatment with the humanized anti-interleukin 6 receptor antibody MRA in rheumatoid arthritis. Phase I/II clinical study.

Norihiro Nishimoto, Kazuyuki Yoshizaki, Keiji Maeda et al. · PubMed · 2003 · 205 citations

Medicine, Pharmacokinetics, Pharmacology +17

Identification and Characterization of Three Novel β1,3-N-Acetylglucosaminyltransferases Structurally Related to the β1,3-Galactosyltransferase Family

Norihiko Shiraishi, Ayumi Natsume, Akira Togayachi et al. · Journal of Biological Chemistry · 2001 · 141 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +11

Trifluoroacetic acid-catalyzed 1,3-cycloaddition of the simplest iminium ylide leading to 3- or 3,4-substituted pyrrolidines and 2,5-dihydropyrroles.

Yoshiyasu Terao, Hiromi Kotaki, Nobuyuki Imai et al. · Chemical and Pharmaceutical Bulletin · 1985 · 90 citations · Full text

Natural Sciences, Chemistry, Organic Chemistry +10

A catalytic enantioselective reaction using a C-symmetric disulfonamide as a chiral ligand: Simmons-Smith cyclopropanation of allylic alcohols by the Et2Zn-CH2I2-disulfonamide system

Hideyo Takahashi, Masato Yoshioka, Masakatsu Shibasaki et al. · Tetrahedron · 1995 · 83 citations

Natural Sciences, Chemical Engineering, Chemistry +9